Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis ...

What if you could save 98 percent of CO₂ emissions during surgery with just one change? And what if that change also improved patient recovery and saved costs? Then you's probably want to implement ...